ZNF671 and central nervous system cancer: Expression analysis showed that ZNF671 was obviously downregulated in GBM, glioma, AST, ODG, LUAD, MEL, and BRCA (Figure 1), which indicated that ZNF671 might play an important role in tumor progression.